Related Experiment Video

Updated: Jun 2, 2026

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

Expression of MicroRNA-146a in peripheral blood mononuclear cells in patients with systemic lupus erythematosus

Wang Hai-yan1, Li Yang, Chen Mei-hong

  • 1Department of Rheumatology, PUMC Hospital, CAMS and PUMC, Beijing 100730, China.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae
|May 3, 2011
PubMed
Abstract

Insights

MicroRNA (miRNA) expression is altered in systemic lupus erythematosus (SLE). Specifically, hsa-miR-146a levels are significantly lower in SLE patients, suggesting its involvement in SLE pathogenesis.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with complex pathogenesis.
  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are implicated in various diseases.
  • Understanding miRNA dysregulation in SLE is crucial for identifying novel therapeutic targets.

Purpose of the Study:

  • To investigate the expression patterns of miRNAs in peripheral blood mononuclear cells (PBMCs) of SLE patients.
  • To identify the potential role of specific miRNAs in the pathogenesis of SLE.
  • To explore hsa-miR-146a as a potential biomarker in SLE.

Main Methods:

  • Literature search for SLE-related genes.
  • Utilized miRNA target gene prediction databases to identify potential miRNA targets.
  • Performed quantitative real-time polymerase chain reaction (qRT-PCR) to measure hsa-miR-146a expression levels in PBMCs from SLE patients and healthy controls.

Main Results:

  • The cycle threshold (Ct) values for hsa-miR-146a were significantly higher in the SLE group (4.52±1.18) compared to the control group (2.76±1.38) (P=0.02).
  • This indicates a significantly lower expression level of hsa-miR-146a in the PBMCs of SLE patients.
  • The findings suggest a downregulation of hsa-miR-146a in SLE.

Conclusions:

  • The expression of hsa-miR-146a is decreased in patients with systemic lupus erythematosus.
  • This downregulation suggests that hsa-miR-146a may play a significant role in the pathogenesis of SLE.
  • Further research into hsa-miR-146a could elucidate its specific mechanisms in SLE development and progression.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...